Unique ID issued by UMIN | UMIN000058054 |
---|---|
Receipt number | R000066355 |
Scientific Title | The study of the changes in defecation information by ingestion of probiotic food |
Date of disclosure of the study information | 2025/06/12 |
Last modified on | 2025/06/02 16:39:07 |
The study of the changes in defecation information by ingestion of probiotic food
The study of the changes in defecation information by ingestion of probiotic food
The study of the changes in defecation information by ingestion of probiotic food
The study of the changes in defecation information by ingestion of probiotic food
Japan |
Healthy adults
Adult |
Others
NO
To investigate the changes in defecation information by constant ingestion of probiotic food
Efficacy
Defecation-related indicator
Interventional
Single arm
Non-randomized
Open -no one is blinded
Self control
1
Prevention
Food |
Ingest of probiotic food during the 4-week intervention period
18 | years-old | <= |
65 | years-old | >= |
Male and Female
1.Those whose workplace is the TOTO Research Institute on the date of consent
2.Those who have received sufficient explanation about the purpose and content of this study, have the ability to consent, fully volunteered with voluntary intention, agreed to participate
1.Those who regularly use medicines that affect the intestinal environment, such as Intestinal regulator, constipation medicine, laxative.
2.Those who cannot stop taking foods for specified health uses, foods with functional claims, health foods, or foods containing lactobacillus, bifidobacterium, oligosaccharides, etc. during the study period.
3.Those who have a disease of the liver, kidneys, heart, lungs, digestive system, blood, endocrine system, or metabolism, or those who have a serious medical history of such diseases.
4.Those who have a serious drug or food allergy or a history of serious allergies.
5.Those who have a milk allergy or lactose intolerance.
6.Those who are pregnant, intend to become pregnant during the study period, or are breastfeeding.
7.Those who have participated in other drug or food trials within the past month, or those who intend to participate in such trials during the study.
8.Those who are deemed unsuitable as subjects by the study physician based on the results of the subject background, etc.
15
1st name | Masayuki |
Middle name | |
Last name | Oba |
TOTO LTD. Research Institute
Life Science R&D Dept
253-8577
2-8-1, Honson, Chigasaki-City, KANAGAWA Pref., JAPAN
0467-54-3380
masayuki.oba@jp.toto.com
1st name | Ayano |
Middle name | |
Last name | Hosokawa |
TOTO LTD. Research Institute
Life Science R&D Dept
253-8577
2-8-1, Honson, Chigasaki-City, KANAGAWA Pref., JAPAN
0467-54-3387
ayano.hosokawa@jp.toto.com
TOTO LTD. Research Institute
TOTO LTD.
Profit organization
Japan Conference of Clinical Research
1-13-23 Minami-ikebukuro, Toshima-Ku, Tokyo, Japan
03-6868-7011
jccr-info@jccr.jp
NO
2025 | Year | 06 | Month | 12 | Day |
Unpublished
Preinitiation
2025 | Year | 04 | Month | 28 | Day |
2025 | Year | 06 | Month | 16 | Day |
2025 | Year | 10 | Month | 31 | Day |
2025 | Year | 06 | Month | 02 | Day |
2025 | Year | 06 | Month | 02 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066355